Economic impact of intermittent intravenous outpatient treatment with levosimendan in patients with advanced heart failure
28 May 2018 (17:54 - 18:00)
Organised by:
About the speaker
Bellvitge University Hospital, Hospitalet De Llobregat (Spain)
14 More presentations in this session
Professor M. Abdelhamid (Cairo, EG)
Miss J. Ter Maaten (Groningen, NL)
Doctor A. Urbinati (New York, US)
Access the full session
The Event
Heart Failure 2018
28 May 2018
17:54 CET
You may be interested in
Congress Session
